Medifar Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing

Secondary Activities: All Other Food Manufacturing | All Other Miscellaneous Food Manufacturing | Soap and Other Detergent Manufacturing | Toilet Preparation Manufacturing | All Other Chemical Product and Preparation Manufacturing | All Other Miscellaneous Chemical Product and Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers

Full name: Medifar Sp. z o.o.

Profile Updated: January 22, 2025

Medifar Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Pharmaceutical Preparation Manufacturing industry. It was incorporated on July 16, 2021. In 2025, the company reported a net sales revenue increase of 4.35%. Its’ total assets recorded a negative growth of 17.79%. In 2025, Medifar Sp. z o.o.’s net profit margin decreased by 0.1%.

Headquarters
Ul. Franciszka Klimczaka 1
Warsaw; Mazowieckie; Postal Code: 02-797

Contact Details: Purchase the Medifar Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Medifar Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Medifar Sp. z o.o. report to view the information.

Incorporation Date:

July 16, 2021

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Vice President

Ownership Details

Purchase this report to view the information.

48.5%

Purchase this report to view the information.

48.5%

Company Performance

Financial values in the chart are available after Medifar Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

4.35%▲

Total Operating Revenue

-5.87%▼

Operating Profit

-10.6%▼

Net Profit/Loss for the Period

-11.34%▼

Total Assets

-17.79%▼

Total Equity

-7.19%▼

Operating Profit Margin

-0.09%▼

Net Profit Margin

-0.1%▼

Return on Equity (ROE)

-1.29%▼

Quick Ratio

1.17%▲

Similar companies